Nvidia Dips, Miners Slump, and a Biotech Stock Soars on a Wild Monday
It was a chaotic midday session on Wall Street. Ultragenyx Pharmaceutical shares cratered over 40% after a key drug trial failure, while falling gold and silver prices dragged mining stocks like Newmont down more than 5%. Meanwhile, Nvidia dipped nearly 2% after its record $20 billion acquisition.